ARCHIVES

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

This article is from The Cancer Letter archive.

Vol. 31 No. 39 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Steckel Object To Remarks By Korn Comparing Southern California Centers Unfavorably To NCCP Consortium

November 2, 1984

Firm Buys Rights To NKT Cells From Beth Israel Deaconess.

July 28, 2000

Phase III Regorafenib Trial Meets PFS Primary Endpoint

June 29, 2012

NCI Is On “Path To Stability,” Sondik Tells House Committee

April 7, 1995

Cervical Screening Should Emphasize Older Women, ASP Members Told

March 14, 1986

In Brief: McDonnell Foundation Selects Five For Awards; James Benson Is Named Interim FDA Head

November 24, 1989